Aaron McDade is a breaking news reporter for Investopedia. He is an experienced journalist who has covered everything from the latest in business and tech news to sports and international news ...

Advanced Micro Devices on Wednesday announced a new $6 billion stock buyback plan, joining a string of chipmakers that are looking to reduce their float as the AI trade that has powered their ...

Semiconductor manufacturer Advanced Micro Devices (AMD) announced a $6 billion share buyback program, pushing the chip stock higher by nearly 7% in Wednesday's pre-market trading (at the time of ...

The Federal Communications Commission said Friday it was approving Verizon Communications’s $20 billion deal to acquire fiber-optic internet providers Frontier Communications after the largest ...

Revenue at Matterport reached nearly $170 million in fiscal year 2024, up 8% from a year earlier. Subscription revenue rose 14% to $99.5 million. The company, however, recorded a net loss of $256 ...

SYRUP isn’t a meme coin. It’s the incentive layer for Maple Finance, the on-chain credit platform managing over $1.6 billion in assets—and growing. In May alone, $60 million in new inflows ...

Hinge Health (HNGE) said on Tuesday that it expects a valuation of up to $2.6B in its initial public offering in the U.S., filed in March this year. The digital health company has applied to list ...

Advanced Micro Devices shares jumped Wednesday, as the chip designer said its board approved a new $6 billion share buyback plan. The move will boost AMD's buyback program to $10 billion, the ...

The Commonwealth Bank of Australia (ASX: CBA) share price is edging higher on Wednesday morning. At the time of writing, the banking giant's shares are up almost 1% to $167.42. This follows the ...

Data security business Cyera is set to be valued at $6 billion in a new investment round, according to people with knowledge of the matter. The $500 million financing would almost double the ...

Regeneron Pharmaceuticals will acquire 23andMe's assets for $256 million, both companies said. 23andMe filed for Chapter 11 bankruptcy earlier this year. The DNA testing company has faced major ...

Pfizer Inc. is paying $1.25 billion up front and up to $4.8 billion in milestone payments to gain global, ex-China rights to SSGJ-707, a PD-1/VEGF bispecific antibody from 3Sbio Inc. that recently won ...